Yolk sac tumours revisited. A review of their many faces and names

Histopathology

Volumn 60, Issue 7, 2012, Pages 1023-1033

  Nogales, Francisco F ^a   Preda, Ovidiu ^a   Nicolae, Alina ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

AFP; Glypican 3; Human yolk sac; Nomenclature; Primitive endodermal tumours; Yolk sac tumour

Indexed keywords

ALPHA FETOPROTEIN; ANTIBODY; GLYPICAN 3; IMP 3 ANTIBODY; LIN28 ANTIBODY; SALL4 ANTIBODY; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR HEPPAR1; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; CELL TYPE; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; EMBRYOLOGY; ENDODERM; FETUS MEMBRANE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MESENCHYMAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; STOMACH CARCINOMA; YOLK SAC TUMOR;

ALPHA-FETOPROTEINS; ANIMALS; ENDODERM; ENDODERMAL SINUS TUMOR; FEMALE; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; MALE; MESODERM; NEOPLASTIC STEM CELLS; PLURIPOTENT STEM CELLS; PREGNANCY; TERMINOLOGY AS TOPIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; YOLK SAC;

MURINAE;

EID: 84861481010     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03889.x     Document Type: Review

References (130)

1. Damjanov I, Damjanov A, Wewer UM. Yolk sac carcinoma: history of the concept and the experimental models. In Nogales FF ed. The human yolk sac and yolk sac tumor. Berlin; New York: Springer-Verlag, 1993; 195-215.
2. Young RH. A brief history of the pathology of the gonads. Mod. Pathol. 2005; 18(Suppl. 2); S3-S17.
3. Nogales FF. The human yolk sac and yolk sac tumors. Berlin; New York: Springer-Verlag, 1993.
4. White CP. A case of carcinoma myxomatodes of the testis occurring in infancy. J. Pathol. Bacteriol. 1910; 14; 522-561.
5. Magner D, Campbell JS, Wiglesworth FW. Testicular adenocarcinoma with clear cells, occurring in infancy. Cancer 1956; 9; 165-175.
6. Teoh TB, Steward JK, Willis RA. The distinctive adenocarcinoma of the infant's testis: an account of 15 cases. J. Pathol. Bacteriol. 1960; 80; 147-156.
7. Schiller W. Mesonephroma ovarii. Am. J. Cancer 1939; 35; 1-21.
8. Kazancigil TR, Laqueur W, Ladewig P. Papillo-endothelioma ovarii; report of 3 cases and discussion of Schiller's 'mesonephroma ovarii'. Am. J. Cancer 1940; 40:199-212.
9. Stowens D. Pediatric pathology. Baltimore: Williams & Wilkins Co., 1966.
10. Willis RA. The pathology of the tumors of children. Edinburgh: Oliver and Boyd, 1962; 61-63.
11. Pierce GB, Dixon FJ Jr. Testicular teratomas II. Teratocarcinoma as an ascitic tumor. Cancer 1959; 12; 584-589.
12. Pierce GB, Dixon FJ Jr. Testicular teratomas I. Demonstration of teratogenesis by metamorphosis of multipotential cells. Cancer 1959; 12; 573-583.
13. Stevens LC, Little CC. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Natl Acad. Sci. USA 1954; 40; 1080-1087.
14. Stevens LC. Origin of testicular teratomas from primordial germ cells in mice. J. Natl Cancer Inst. 1967; 38; 549-552.
15. Pierce GB Jr, Midgley AR Jr, Ram JS et al. Pariental yolk sac carcinoma: clue to the histogenesis of Riechert's membrane of the mouse embryo. Am. J. Pathol. 1962; 41; 549-566.
16. Pierce GB, Bullock WK, Huntington RW Jr. Yolk sac tumors of the testis. Cancer 1970; 25; 644-658.
17. Mostofi FK, Price EB Jr. Tumors of the male genital system. Atlas of tumor pathology. 2nd series, Fascicle No. 8. Washington DC: Armed Forces Institute of Pathology, 1973.
18. Mostofi FK, Sobin LH. Histological typing of testis tumours. International histological classification of tumours. Geneva: World Health Organization, 1976.
19. Pugh RCB. Pathology of the testis. Oxford: Blackwell Scientific, 1976; 139-159.
20. Duval M. Le placenta des rongeurs. J. Anat. Physiol. (Paris) 1891; 27; 344-395.
21. Pijnenborg R, Vercruysse L. Mathias Duval on placental development in mice and rats. Placenta 2006; 27; 109-118.
22. Scully RE, Barlow JF. 'Mesonephroma' of ovary. Tumor of Mullerian nature related to the endometrioid carcinoma. Cancer 1967; 20; 1405-1417.
23. Teilum G. Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesoephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat's placenta. Cancer 1959; 12; 1092-1105.
24. Teilum G. Homologous ovarian and testicular tumors: I. With discussion of 'mesonephroma ovarii' (Schiller). Acta. Path. Microbiol. Scand. 1946; 23:242-251.
25. Teilum G. 'Mesonephroma ovarii' (Schiller). An extraembryonic mesoblastoma of germ cell origin in the ovary and the testis. Acta. Pathol. Microbiol. Scand. 1950; 27; 249-261.
26. Teilum G, Albrechtsen R, Norgaard-Pedersen B. Immunofluorescent localization of alpha-fetoprotein synthesis in endodermal sinus tumor (yolk sac tumor). Acta. Pathol. Microbiol. Scand. A 1974; 82; 586-588.
27. Ito T, Shirai T, Naka A et al. Yolk sac tumor and alpha-fetoprotein: clinicopathological study of four cases. Gann 1974; 65; 215-226.
28. Talerman A, Haije WG, Baggerman L. Serum alphafetoprotein (AFP) in patients with germ cell tumors of the gonads and extragonadal sites: correlation between endodermal sinus (yolk sac) tumor and raised serum AFP. Cancer 1980; 46; 380-385.
29. Nogales-Fernandez F, Silverberg SG, Bloustein PA et al. Yolk sac carcinoma (endodermal sinus tumor): ultrastructure and histogenesis of gonadal and extragonadal tumors in comparison with normal human yolk sac. Cancer 1977; 39; 1462-1474.
30. Cohen MB, Mulchahey KM, Molnar JJ. Ovarian endodermal sinus tumor with intestinal differentiation. Cancer 1986; 57; 1580-1583.
31. Kim CR, Hsiu JG, Given FT. Intestinal variant of ovarian endodermal sinus tumor. Gynecol. Oncol. 1989; 33; 379-381.
32. Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer 1976; 38; 2404-2419.
33. Prat J, Bhan AK, Dickersin GR et al. Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases. Cancer 1982; 50; 2355-2368.
34. Clement PB, Young RH, Scully RE. Endometrioid-like variant of ovarian yolk sac tumor. A clinicopathological analysis of eight cases. Am. J. Surg. Pathol. 1987; 11; 767-778.
35. Sadler TW, Langman J. Langman's medical embryology. Baltimore, Md: Lippincott William & Wilkins, 2009.
36. Luckett WP. Origin and differentiation of the yolk sac and extraembryonic mesoderm in presomite human and rhesus monkey embryos. Am. J. Anat. 1978; 152; 59-97.
37. Enders AC, Schlafke S, Hendrickx AG. Differentiation of the embryonic disc, amnion, and yolk sac in the rhesus monkey. Am. J. Anat. 1986; 177; 161-185.
38. Enders AC, King BF. Formation and differentiation of extraembryonic mesoderm in the rhesus monkey. Am. J. Anat. 1988; 181; 327-340.
39. Enders AC, King BF. Development of the Human Yolk Sac. In Nogales FF ed. The human yolk sac and yolk sac tumor. Berlin; New York: Springer-Verlag, 1993; 33-47.
40. Takashina T. Histology of the secondary human yolk sac with special reference to hematopoiesis. In Nogales FF ed. The human yolk sac and yolk sac tumor. Berlin; New York: Springer-Verlag, 1993; 48-69.
41. Takashina T. Haemopoiesis in the human yolk sac. J. Anat. 1987; 151; 125-135.
42. Nogales F, Fernandez PL, Alvaro T. Alfa-fetoprotein-positive globules in involuting human yolk sac. Hum. Pathol. 1988; 19; 995.
43. Gutierrez-Aranda I, Ramos-Mejia V, Bueno C et al. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 2010; 28; 1568-1570.
44. Damjanov I, Solter D. Yolk sac carcinoma grown from mouse egg cylinder. Arch. Pathol. 1973; 92; 182-184.
45. Damjanov I. Animal model: parietovisceral yolk sac carcinoma in the rat. Am. J. Pathol. 1981; 98; 569-572.
46. Kleinsmith LJ, Pierce GB. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 1964; 24; 1544-1551.
47. Vandeputte M, Sobis H, Billiau A et al. In utero tumor induction by murine sarcoma virus (Moloney) in the rat. I. Biological characteristics. Int. J. Cancer 1973; 11; 536-542.
48. Damjanov I, Sell S. Yolk sac carcinoma grown from rat egg cylinders. J. Natl. Cancer Inst. 1977; 58; 1523-1525.
49. Vandeputte M, Sobis H. Experimental rat model for human yolk sac tumor. Eur. J. Cancer Clin. Oncol. 1988; 24; 551-558.
50. Langley FA, Govan AD, Anderson MC et al. Yolk sac and allied tumours of the ovary. Histopathology 1981; 5; 389-401.
51. Sobis H, Van Hove L, Vandeputte M. Trophoblastic and mesenchymal structures in rat yolk sac carcinoma. Int. J. Cancer 1982; 29; 181-186.
52. Damjanov A, Amenta PS, Zarghami F. Transformation of an AFP-positive yolk sac carcinoma into an AFP-negative neoplasm. Evidence for in vivo cloning of the human parietal yolk sac carcinoma. Cancer 1984; 53; 1902-1907.
53. Ulbright TM, Roth LM, Brodhecker CA. Yolk sac differentiation in germ cell tumors. A morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features. Am. J. Surg. Pathol. 1986; 10; 151-164.
54. Michael H, Lucia J, Foster RS et al. The pathology of late recurrence of testicular germ cell tumors. Am. J. Surg. Pathol. 2000; 24; 257-273.
55. Nogales FF Jr, Matilla A, Nogales O et al. Yolk sac tumors with pure and mixed polyvesicular vitelline patterns. Hum. Pathol. 1978; 9; 553-566.
56. Teilum G. Special tumors of ovary and testis and related extragonadal lesions. Comparative pathology and histological identification. Copenhagen: Munksgaard, 1971; 51-59.
57. Nogales FF, Talerman A, Kubik-Huch RA et al. Germ cell tumors. In Tavassoli FA, Devilee P eds. World health organisation classification of tumours pathology and genetics of tumours of the breast and female genital organ. Lyon: IARC Press, 2003; 163-175.
58. Orazi A, Neiman RS, Ulbright TM et al. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993; 71; 3873-3881.
59. Hartman JT, Nichols CR, Droz JP et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J. Natl Cancer Inst. 2000; 92; 54-61.
60. Nogales FF, Bergeron C, Carvia RE et al. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am. J. Surg. Pathol. 1996; 20; 1056-1066.
61. Drut R, Mortera M, Drut RM. Yolk sac tumor of the placenta in Wiedemann-Beckwith syndrome. Pediatr. Dev. Pathol. 1998; 1; 534-537.
62. Garcia-Galvis OF, Cabrera-Ozoria C, Fernandez JA et al. Malignant Mullerian mixed tumor of the ovary associated with yolk sac tumor, neuroepithelial and trophoblastic differentiation (teratoid carcinosarcoma). Int. J. Gynecol. Pathol. 2008; 27; 515-520.
63. Garcia-Galvis OF, Stolnicu S, Munoz E et al. Adult extrarenal Wilms tumor of the uterus with teratoid features. Hum. Pathol. 2009; 40; 418-424.
64. Nogales FF, Beltran E, Pavcovich M. Pathology of ovarian yolk sac tumors. In Nogales FF ed. The human yolk sac and yolk sac tumor. Berlin; New York: Springer-Verlag, 1993; 228-244.
65. Huysentruyt CJ, Vandevijver NM, Jan van Suylen R et al. Adenocarcinoma of the fetal lung-type metastatic to the ovary. Int. J. Gynecol. Pathol. 2010; 29; 339-340.
66. Roth LM. Variants of yolk sac tumor. Pathology Case Reviews 2005; 10; 186-192.
67. Salazar H, Kanbour A, Tobon A et al. Endodermal cell derivatives in embryonal carcinoma of the ovary: an electron microscopy study of two cases. Am. J. Pathol. 1974; 74; 108a. (abstr).
68. Michael A, Ulbright TM, Brodhecker CA. The pluripotential nature of the mesenchyme-like component of yolk sac tumor. Arch. Pathol. Lab. Med. 1989; 113; 1115-1119.
69. Ulbright TM, Loehrer PJ, Roth LM et al. The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer 1984; 54; 1824-1833.
70. Malagon HD, Valdez AM, Moran CA et al. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases. Am. J. Surg. Pathol. 2007; 31; 1356-1362.
71. Motzer RJ, Amsterdam A, Prieto V et al. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J. Urol. 1998; 159; 133-138.
72. Korski K, Breborowicz D, Filas V et al. A case of primary testicular germ cell tumor with rhabdomyosarcoma metastases as an example of applying the FISH method to diagnostic pathology. APMIS 2007; 115; 1296-1301.
73. Nogales FF, Buritica C, Regauer S et al. Mucinous carcinoid as an unusual manifestation of endodermal differentiation in ovarian yolk sac tumors. Am. J. Surg. Pathol. 2005; 29; 1247-1251.
74. Matsuyama TA, Kushima M, Yamochi-Onizuka T et al. Placental yolk sac tumor with divergent endodermal differentiation. Int. J. Gynecol. Pathol. 2004; 23; 398-402.
75. Rutgers JL, Young RH, Scully RE. Ovarian yolk sac tumor arising from an endometrioid carcinoma. Hum. Pathol. 1987; 18; 1296-1299.
76. Thomas J, Adegboyega P, Iloabachie K et al. Sinonasal teratocarcinosarcoma with yolk sac elements: a neoplasm of somatic or germ cell origin? Ann. Diagn. Pathol. 2011; 15; 135-139.
77. Garcia RL, Ghali VS. Gastric choriocarcinoma and yolk sac tumor in a man: observations about its possible origin. Hum. Pathol. 1985; 16; 955-958.
78. Kawahara M, Takada A, Tachibana A et al. Germ cell tumor of the colon with an adenocarcinomatous component. Int. J. Clin. Oncol. 2009; 14; 537-540.
79. Taylor G, Jordan M, Churchill B et al. Yolk sac tumor of the bladder. J. Urol. 1983; 129; 591-594.
80. Salem F, Rosenblum MK, Jhanwar SC et al. Teratocarcinosarcoma of the nasal cavity and paranasal sinuses: report of 3 cases with assessment for chromosome 12p status. Hum. Pathol. 2008; 39; 605-609.
81. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010; 143; 508-525.
82. Geijsen N, Horoschak M, Kim K et al. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 2004; 427; 148-154.
83. Suzuki S, Terauchi M, Umezu T et al. Identification and characterization of cancer stem cells in ovarian yolk sac tumors. Cancer Sci. 2010; 101; 2179-2185.
84. Marin-Padilla M. Origin, nature and significance of the 'embryoids' of human teratomas. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 1965; 340; 105-121.
85. Nakane PK, Pierce GB Jr. Enzyme-labeled antibodies for the light and electron microscopic localization of tissue antigens. J. Cell Biol. 1967; 33; 307-318.
86. Freyer C, Renfree MB. The mammalian yolk sac placenta. J. Exp. Zool. B. Mol. Dev. Evol. 2009; 312; 545-554.
87. Liu H, Li P, Zhai Y et al. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma. World J. Gastroenterol. 2010; 16; 4410-4415.
88. Yang F, Luna VJ, Mcanelly RD et al. Evolutionary and structural relationships among the group-specific component, albumin and alpha-fetoprotein. Nucleic Acids Res. 1985; 13; 8007-8017.
89. Mizejewski GJ. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp. Biol. Med. (Maywood) 2001; 226; 377-408.
90. El-Bahrawy M. Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract. Eur. J. Cancer 2010; 46; 1317-1322.
91. Ishikawa T, Kashiwagi H, Iwakami Y et al. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction. Jpn. J. Clin. Oncol. 1998; 28; 723-728.
92. Kishimoto T, Yano T, Hiroshima K et al. A case of α-fetoprotein-producing pulmonary carcinoma with restricted expression of hepatocyte nuclear factor-4α in hepatoid foci: a case report with studies of previous cases. Hum. Pathol. 2008; 39; 1115-1120.
93. Tsuchida Y, Kaneko M, Fukui M et al. Three different types of alpha-fetoprotein in the diagnosis of malignant solid tumors: use of a sensitive lectin-affinity immunoelectrophoresis. J. Pediatr. Surg. 1989; 24; 350-355.
94. Kinoshita Y, Tajiri T, Souzaki R et al. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study. J. Pediatr. Hematol. Oncol. 2008; 30; 447-450.
95. De Cat B, David G. Developmental roles of the glypicans. Semin. Cell Dev. Biol. 2001; 12; 117-125.
96. Preda O, Nicolae A, Aneiros-Fernandez J et al. Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumors. Histopathology 2011; 58; 312-314.
97. Maeda D, Ota S, Takazawa Y et al. Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod. Pathol. 2009; 22; 824-832.
98. Yamauchi N, Watanabe A, Hishinuma M et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod. Pathol. 2005; 18; 1591-1598.
99. Nakatsura T, Kageshita T, Ito S et al. Identification of glypican-3 as a novel tumor marker for melanoma. Clin. Cancer Res. 2004; 10; 6612-6621.
100. Umezu T, Shibata K, Kajiyama H et al. Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary. J. Clin. Pathol. 2010; 63; 962-966.
101. Aviel-Ronen S, Lau SK, Pintilie M et al. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma. Mod. Pathol. 2008; 21; 817-825.
102. Ou-Yang RJ, Hui P, Yang XJ et al. Expression of glypican 3 in placental site trophoblastic tumor. Diagn. Pathol. 2010; 5; 64.
103. Zynger DL, McCallum JC, Luan C et al. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology 2010; 56; 750-757.
104. Rao S, Zhen S, Roumiantsev S et al. Differential roles of Sall4 isoforms in embryonic stem cell pluripotency. Mol. Cell. Biol. 2010; 30; 5364-5380.
105. Wang J, Rao S, Chu J et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006; 444; 364-368.
106. Yang J, Gao C, Chai L et al. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS ONE 2010; 5; e10766.
107. Cao D, Li J, Guo CC et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am. J. Surg. Pathol. 2009; 33; 1065-1077.
108. Cao D, Guo S, Allan RW et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am. J. Surg. Pathol. 2009; 33; 894-904.
109. Wang F, Liu A, Peng Y et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am. J. Surg. Pathol. 2009; 33; 1529-1539.
110. Ushiku T, Shinozaki A, Shibahara J et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am. J. Surg. Pathol. 2010; 34; 533-540.
111. Zhong X, Li N, Liang S et al. Identification of MicroRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells. J. Biol. Chem. 2010; 285; 41961-41971.
112. West JA, Viswanathan SR, Yabuuchi A et al. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 2009; 460; 909-913.
113. Cao D, Liu A, Wang F et al. RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases. Mod. Pathol. 2011; 24; 288-296.
114. Hammer NA, Hansen TO, Byskov AG et al. Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. Reproduction 2005; 130; 203-212.
115. Beck F, Stringer EJ. The role of Cdx genes in the gut and in axial development. Biochem. Soc. Trans. 2010; 38; 353-357.
116. Silberg DG, Swain GP, Suh ER et al. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 2000; 119; 961-971.
117. Bing Z, Pasha T, Tomaszewski JE et al. CDX2 expression in yolk sac component of testicular germ cell tumors. Int. J. Surg. Pathol. 2009; 17; 373-377.
118. Lau SK, Luthringer DJ, Eisen RN. Thyroid transcription factor-1: a review. Appl. Immunohistochem. Mol. Morphol. 2002; 10; 97-102.
119. Robens J, Goldstein L, Gown AM et al. Thyroid transcription factor-1 expression in breast carcinomas. Am. J. Surg. Pathol. 2010; 34; 1881-1885.
120. Matoso A, Singh K, Jacob R et al. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl. Immunohistochem. Mol. Morphol. 2010; 18; 142-149.
121. Zhang PJ, Gao HG, Pasha TL et al. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int. J. Gynecol. Pathol. 2009; 28; 10-18.
122. Butler SL, Dong H, Cardona D et al. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab. Invest. 2008; 88; 78-88.
123. Fan Z, van de Rijn M, Montgomery K et al. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod. Pathol. 2003; 16; 137-144.
124. Pitman MB, Triratanachat S, Young RH et al. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Int. J. Gynecol. Pathol. 2004; 23; 58-64.
125. Saksela E. Immunohistochemical markers of yolk sac tumors. In Nogales FF ed. The human yolk sac and yolk sac tumor. Berlin; New York: Springer-Verlag, 1993; 216-227.
126. Gaillard JA. Signification de la tumeur des sinus endodermiques (Teilum) et des teratomes simplifies a determination vitelline. Bull. Cancer 1976; 63; 27-40.
127. Ardila-Jaimes JE, Otero-Andrade FE, Aristizabal-Aristizabal A et al. Tumor del saco de Yolk: reporte de un caso clínico y revisión de la literatura. Urologia Colombiana 2008; 17; 121-128.
128. Dehner LP. Primitive neuroectodermal tumor and Ewing's sarcoma. Am. J. Surg. Pathol. 1993; 17; 1-13.
129. Mackinnon AE, Cohen SJ. Archenteronoma (yolk sac tumors). J. Pediatr. Surg. 1978; 13; 21-23.
130. Nogales FF, Buritica C, Godoy C. A dislike for endometrioid-like. Histopathology 2006; 49; 315-316.